|
RBBP6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.544300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.346100E-02 |
| Normal-vs-Stage2 |
5.862800E-01 |
| Normal-vs-Stage3 |
1.965570E-01 |
| Normal-vs-Stage4 |
5.599600E-01 |
| Stage1-vs-Stage2 |
6.778600E-01 |
| Stage1-vs-Stage3 |
8.208600E-01 |
| Stage1-vs-Stage4 |
9.454000E-01 |
| Stage2-vs-Stage3 |
6.155800E-01 |
| Stage2-vs-Stage4 |
8.440200E-01 |
| Stage3-vs-Stage4 |
8.518600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.137680E-02 |
| Normal-vs-AfricanAmerican |
5.017000E-01 |
| Normal-vs-Asian |
5.521000E-01 |
| Caucasian-vs-AfricanAmerican |
8.001500E-02 |
| Caucasian-vs-Asian |
2.864200E-01 |
| AfricanAmerican-vs-Asian |
4.651000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.195900E-02 |
| Normal-vs-Female |
2.185900E-02 |
| Male-vs-Female |
3.005800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.453400E-01 |
| Normal-vs-Extreme_Weight |
1.022610E-01 |
| Normal-vs-Obese |
3.481600E-02 |
| Normal-vs-Extreme_Obese |
8.738400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.860400E-01 |
| Normal_Weight-vs-Obese |
3.692200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.845800E-01 |
| Extreme_Weight-vs-Obese |
5.485200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.215400E-01 |
| Obese-vs-Extreme_Obese |
3.500000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.557980E-02 |
| Normal-vs-Age(41-60Yrs) |
9.836000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.561410E-01 |
| Normal-vs-Age(81-100Yrs) |
5.952400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.454800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.130600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.451600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.756380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.014360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.232400E-04 |
| Normal-VS-Type2 PRCC |
2.636200E-01 |
| Normal-VS-KIRP CIMP |
2.572800E-01 |
| Normal-VS-Unclassified PRCC |
7.489800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.27159999999227E-05 |
| Type1 PRCC-VS-KIRP CIMP |
5.368800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.221200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.960810E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.162190E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.486600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.931600E-01 |
| Normal-vs-N1 |
4.607500E-02 |
| Normal-vs-N2 |
8.647200E-01 |
| N0-vs-N1 |
1.671730E-02 |
| N0-vs-N2 |
8.012200E-01 |
| N1-vs-N2 |
4.278400E-01 |
|
|
